Neautus looks outward to boost its traditional medicine story
The maker of traditional Chinese medicines has applied for a Hong Kong IPO after abandoning two listing attempts on China’s domestic A-share market Key Takeaways: Neautus has applied to list…
Recent Articles
RELATED ARTICLES
-
TCMTech fuses old with the new by mixing AI and Chinese medicine
-
BRIEF: China Traditional Chinese Medicine’s profit tumbles in 2024
0570.HK
-
Haitian looks for new financial flavor in Hong Kong IPO
603288.SHG
- Zhida looks for IPO charge as EV distress drains its coffers
-
Miniso struggles to impress investors, even with a successful ‘toy story’
9896.HK MNSO.US
- From its ‘liquor lookalike’ roots, Dayao crafts a new beverage story for the young
-
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
